Evolving platform
Colin Kerr
Published: Tuesday, May 1, 2018
LENSAR has received 510(k) clearance from the US Food and Drug Administration for the LENSAR Laser System with Streamline IV, expanding the platform’s capabilities to include the creation of the corneal pockets and flaps used in ophthalmic procedures treating presbyopia.
“The continued expansion of capabilities with the LENSAR Laser System is the latest demonstration of our commitment to technological innovation,” said Nicholas Curtis, CEO of LENSAR. “It made sense to evolve our platform to support surgeons meeting the increasing patient demand with options for the treatment of presbyopia with corneal inlay devices.”
http://www.lensar.com/
Latest Articles
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.
AI Analysis and the Cornea
A combination of better imaging and AI deep learning could significantly improve corneal imaging and diagnosis.
Cooking a Feast for the Eyes
A cookbook to promote ocular health through thoughtful and traditional cuisine.
Need to Know: Spherical Aberration
Part three of this series examines spherical aberration and its influence on higher-order aberrations.
Generating AI’s Potential
How generative AI impacts medicine, society, and the environment.